VICAL INC (153) | Business Operations (8)

Browse by Subcategory

Indemnification Agreements (2 contracts)
Sales Agreements (1)
Settlement Agreements (1)
Supply Agreements (3)
Termination Agreements (1)

Recent Contracts

Form of Indemnification Agreement by and between the Company and its directors and executive officers (Filed With SEC on March 30, 2023)
Letter Agreement for Supply of API, dated as of December 8, 2020, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd (Filed With SEC on March 9, 2021)
Form of Indemnification Agreement by and between the Company and its directors and executive officers (Filed With SEC on August 12, 2020)
Clinical Supply Agreement, dated as of July 30, 2019, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd., and First Amendment to Clinical Supply Agreement,... (Filed With SEC on June 8, 2020)
Letter Agreement for Supply of API, dated as of April 26, 2020, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd (Filed With SEC on June 8, 2020)
At Market Issuance Sales Agreement, dated April 14, 2020, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on April 14, 2020)
Settlement Agreement, dated February 17, 2020, by and among Brickell Biotech, Inc., Brickell Subsidiary, Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor (Filed With SEC on February 18, 2020)
SETTLEMENT AND TERMINATION AGREEMENT (Filed With SEC on November 25, 2019)